A Study to Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer
Clinical trial NCT00958477 · COMPLETED
Trial details
- NCT number
- NCT00958477
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2010-09-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.